Boxer Capital, LLC’s Kalvista Pharmaceuticals Inc Position
Does Boxer Capital, LLC own Kalvista Pharmaceuticals Inc (4XC1)? Not currently — the last reported position was 1.59M shares worth $18M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$18M
Q3 2024
Shares
1.59M
% of Portfolio
+0.90%
Quarters Held
12
position exited
Position History 4XC1
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 1.59M | $18M | +0.90% |
| Q2 2024 | 1.59M | $19M | +0.99% |
| Q1 2024 | 1.59M | $19M | +0.93% |
| Q4 2023 | 1.65M | $20M | +1.01% |
| Q3 2023 | 1.65M | $16M | +0.85% |
| Q2 2023 | 1.65M | $14,850 | +0.69% |
| Q1 2023 | 1.65M | $12,969 | +0.64% |
| Q4 2019 | 200.0K | $4M | +0.20% |
| Q3 2019 | 200.0K | $2M | +0.17% |
| Q2 2019 | 200.0K | $4M | +0.38% |
| Q1 2019 | 200.0K | $6M | +0.66% |
| Q4 2018 | 200.0K | $4M | +0.49% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of 4XC1.